JENNIFER DAVIS: Open Payments
NPI 1861074775 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,558 in 67 payments from 25 companies in 2025. Trend: 2023 $900 · 2024 $2,207 · 2025 $1,558
Food & beverage: $1,481Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $292 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| Novartis Pharmaceuticals Corporation | 6 | $144 |
| Janssen Biotech, Inc. | 4 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $139 |
| GlaxoSmithKline, LLC. | 1 | $103 |
| Ardelyx, Inc. | 3 | $75 |
| Grifols USA, LLC | 3 | $61 |
| Lilly USA, LLC | 3 | $52 |
| Madrigal Pharmaceuticals | 2 | $37 |
Products named: AIRSUPRA, TREMFYA, Rhapsido, CREON, EOHILIA, IBSRELA, RINVOQ, SKYRIZI.
Industry payments across TX — which companies pay providers there.
